Brompheniramine during pregnancy and lactaion

Brompheniramine during pregnancy and lactation, Brompheniramine category by FDA, its use during pregnancy and lactation its teratogenic effects are described.

Small amount of drug excrete into breast milk, if required low dose should be prescribed.

Brompheniramine  during pregnancy and lactation
Pregnancy	Category  C      ( by FDA )
	Brompheniramine Not much adequate studies for the safety of drug, Animal studies have not been reported. There are no controlled data in human pregnancy.
Breast feeding	Brompheniramine not recommended during breast feeding, no adequate controlled studies.